ES2548902T3 - Procedimiento para la identificación de moduladores de catecol O-metiltransferasa - Google Patents

Procedimiento para la identificación de moduladores de catecol O-metiltransferasa Download PDF

Info

Publication number
ES2548902T3
ES2548902T3 ES11738203.6T ES11738203T ES2548902T3 ES 2548902 T3 ES2548902 T3 ES 2548902T3 ES 11738203 T ES11738203 T ES 11738203T ES 2548902 T3 ES2548902 T3 ES 2548902T3
Authority
ES
Spain
Prior art keywords
catechol
methyltransferase
identification
procedure
comt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11738203.6T
Other languages
English (en)
Inventor
Thilo Enderle
Doris Roth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2548902T3 publication Critical patent/ES2548902T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91005—Transferases (2.) transferring one-carbon groups (2.1)
    • G01N2333/91011—Methyltransferases (general) (2.1.1.)
    • G01N2333/91017—Methyltransferases (general) (2.1.1.) with definite EC number (2.1.1.-)
    • G01N2333/91022—Catecholmethyltransferases (2.1.1.6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

Un procedimiento para la identificación de un modulador de la actividad de la enzima catecol Ometiltransferasa (COMT) que comprende las etapas de: a) proporcionar 4-nitrocatecol ligado covalentemente con Alexa Fluor 488 que tiene la fórmula I, b) poner en contacto la molécula de la etapa a) con una enzima catecol O-metiltransferasa (COMT), Sadenosilmetionina (SAM) y un compuesto candidato y c) medir la lectura de fluorescencia de la mezcla de la etapa b), en el que una lectura de fluorescencia alterada en presencia del compuesto candidato en comparación con un blanco es indicativa de un modulador de enzima catecol O-metiltransferasa (COMT).**Fórmula**

Description

imagen1
imagen2
imagen3
imagen4

Claims (1)

  1. imagen1
    imagen2
ES11738203.6T 2010-07-27 2011-07-25 Procedimiento para la identificación de moduladores de catecol O-metiltransferasa Active ES2548902T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10170957 2010-07-27
EP10170957 2010-07-27
PCT/EP2011/062704 WO2012013614A1 (en) 2010-07-27 2011-07-25 Method for the identification of catechol o-methyltransferase modulators

Publications (1)

Publication Number Publication Date
ES2548902T3 true ES2548902T3 (es) 2015-10-21

Family

ID=44629285

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11738203.6T Active ES2548902T3 (es) 2010-07-27 2011-07-25 Procedimiento para la identificación de moduladores de catecol O-metiltransferasa

Country Status (11)

Country Link
US (1) US20130217595A1 (es)
EP (1) EP2598886B1 (es)
JP (1) JP5709285B2 (es)
KR (1) KR20130059390A (es)
CN (1) CN103026236B (es)
BR (1) BR112013001595A2 (es)
CA (1) CA2804856A1 (es)
ES (1) ES2548902T3 (es)
MX (1) MX2013000651A (es)
RU (1) RU2535125C2 (es)
WO (1) WO2012013614A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104655705B (zh) * 2015-02-12 2017-03-08 江苏省原子医学研究所 一种用毛细管电泳快速检测生物样本中儿茶酚氧甲基转移酶comt活性的方法
CN106148430B (zh) * 2015-04-02 2019-09-06 中国科学院大连化学物理研究所 一种生物催化儿茶酚类化合物烃基化的方法
CN105734114B (zh) * 2016-03-10 2019-01-25 北京中科唯新生物医学研究所有限公司 一种儿茶酚-o-甲基转移酶酶活力检测试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005126402A (ja) * 2003-10-21 2005-05-19 Katsutoshi Terasawa Ｃｏｍｔ阻害剤
EP1674580A1 (en) * 2004-12-23 2006-06-28 F. Hoffmann-La Roche Ag Method for identifying activators and/or inhibitors of enzyme activity
MY148644A (en) * 2005-07-18 2013-05-15 Orion Corp New pharmaceutical compounds

Also Published As

Publication number Publication date
CN103026236A (zh) 2013-04-03
EP2598886B1 (en) 2015-08-19
BR112013001595A2 (pt) 2016-05-17
KR20130059390A (ko) 2013-06-05
RU2013106221A (ru) 2014-09-10
HK1183516A1 (en) 2013-12-27
JP2013532479A (ja) 2013-08-19
MX2013000651A (es) 2013-03-22
US20130217595A1 (en) 2013-08-22
CN103026236B (zh) 2015-01-07
EP2598886A1 (en) 2013-06-05
JP5709285B2 (ja) 2015-04-30
RU2535125C2 (ru) 2014-12-10
WO2012013614A1 (en) 2012-02-02
CA2804856A1 (en) 2012-02-02

Similar Documents

Publication Publication Date Title
ES2507520T3 (es) Aislamiento y/o identificación de células madre con potencial de diferenciación adipocitario, condrocitario y pancreático
CL2008003910A1 (es) Formulacion liquida, estable, conteniendo anticuerpo que comprende arginina y metionina; procedimiento para inhibir la deamidacion de moleculas de un anticuerpo que comprende agregar arginina a la formulacion liquida.
CL2020002805A1 (es) Método para identificar un modulador de un sistema biológico; método para identificar un modulador de un proceso de enfermedad (divisional 201302526)
ES2628944T3 (es) Método para la evaluación de la función de fagocitos
MX2020000481A (es) Uso de proteína cas, método para detectar moléculas de ácido nucleico objetivo y kit.
MX356986B (es) Metodo para detectar aductos de nucleosomas.
ES2525918T3 (es) Proceso para la fabricación de Nicorandil
BRPI1011516A8 (pt) Aglomerado de pelo menos uma partícula p, processo para a produção de aglomerados, e, uso dos aglomerados.
CL2008002845A1 (es) Metodo para preparar un catalizador que comprende poner en contacto un soporte con un compuesto de titanio trivalente y un compuesto que contiene cromo; catalizador de polimerizacion; y composicion de catalizador.
BR112014030210A2 (pt) métodos e aparelhos para determinar impressões usando informações demográficas distribuídas
MX2013001042A (es) Biomarcadores de cancer pancreatico y usos de los mismos.
CL2009000178A1 (es) Composicion que comprende un anticuerpo contra el dominio ii de her2, sus variantes acidas, secuencias que comprenden las cadenas livianas y pesadas de este; formulacion farmaceutica que comprende dicho anticuerpo y uso de este para cancer her2 positivo.
MX355416B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
BR112021022865A2 (pt) Matriz e método para detectar informações espaciais de ácidos nucleicos
BR112014019090A8 (pt) Método e aparelho
BR112016021929A2 (pt) Método, dispositivo e conjunto para a avaliação da qualidade de uma amostra de produto, conjunto de dados, meio de armazenamento de dados, uso dos rotuladores e método para o fornecimento de uma coleção de produtos
BR112013006496A2 (pt) método e sistema para determinar a fricção potencial um pneu e uma superfície de rolagem
BR112012012642A2 (pt) composição, e, métodos para dispersar pelo menos uma partícula em um meio aquoso e para produzir um um dispersante polimérico
BR112013025777A2 (pt) imidazopiridazinas como inibidores da quinase akt
ECSP11011376A (es) Dispositivo y procedimiento para la verificación y para el análisis cuantitativo de analitos, particularmente de micotoxinas
ES2684758T3 (es) Procedimiento para diagnosticar fibrosis hepática
CL2014000451A1 (es) Metodo para sedar, anestesiar o someter a eutanasia un organismo acuático que comprende poner en contacto dicho organismo con linalol; composición que comprende linalol y al menos un solvente o surfactante.
ES2496447T3 (es) Procedimiento de preparación de un aminoácido a partir de 2-aminobutirolactona
BR112014014279A2 (pt) método para obter dados úteis para o diagnóstico e/ou prognóstico de insuficiência renal aguda; uso de pelo menos um micro-rna; kit para o diagnóstico e/ou prognóstico de insuficiência renal aguda e uso do kit
BRPI0704496A (pt) pigmentos de óxido férrico estáveis à oxidação, processo para a fabricação de pigmentos de óxido férrico, uso dos pigmentos de óxido férrico